Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series

被引：5
|
作者：
Magen, Hila [1 ,2 ]
Geva, Mika [1 ,2 ]
Volchik, Yulia [1 ]
Avigdor, Abraham [1 ,2 ]
Nagler, Arnon [1 ,2 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Dept Hematol, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷 / 12期
关键词：
Heavily treated patients; Hematologic malignancies; Relapsing/refractory multiple myeloma; Selective inhibitor of nuclear export; Treatment response; TOPOISOMERASE-II; ORAL SELINEXOR; NUCLEAR EXPORT; INHIBITION; DIAGNOSIS; CRITERIA; CELLS;
D O I：
10.1016/j.clml.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E947 / E955
页数：9
相关论文
共 50 条
  • [21] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Migliaccio, I.
    Zacheo, I.
    Di Perna, M.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 139 - 140
  • [22] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ronconi, Sonia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E359 - E359
  • [23] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Nappi, Davide
    Catalano, Lucio
    Pane, Fabrizio
    Martinelli, Giovanni
    Cerchione, Claudio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S442 - S442
  • [24] Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
    Richardson, Paul G.
    Oriol, Albert
    Larocca, Alessandra
    Blade, Joan
    Cavo, Michele
    Rodriguez-Otero, Paula
    Leleu, Xavier
    Nadeem, Omar
    Hiemenz, John W.
    Hassoun, Hani
    Touzeau, Cyrille
    Alegre, Adrian
    Paner, Agne
    Maisel, Christopher
    Mazumder, Amitabha
    Raptis, Anastasios
    Moreb, Jan S.
    Anderson, Kenneth C.
    Laubach, Jacob P.
    Thuresson, Sara
    Thuresson, Marcus
    Byrne, Catriona
    Harmenberg, Johan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (07) : 757 - +
  • [25] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Migliaccio, I
    Zacheo, I
    Di Perna, M.
    Peluso, I
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : 39 - 39
  • [26] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Pareto, A. E.
    Musuraca, G.
    Lucchesi, A.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S105 - S105
  • [27] Selinexor and dexamethasone in multiple myeloma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (03): : E146 - E146
  • [28] Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily PreTreated Multiple Myeloma: Old/New in the Novel Agents' Era
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Rocco, Stefano
    Palmieri, Salvatore
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Ferrara, Felicetto
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S310 - S310
  • [29] Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pretreated Multiple Myeloma: Old/New in NOVEL Agents' Era
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Rocco, Stefano
    Palmieri, Salvatore
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Ferrara, Felicetto
    Martinelli, Giovanni
    BLOOD, 2020, 136
  • [30] Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pretreated Multiple Myeloma: Old/New in Novel Agents' Era
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ronconi, Sonia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E359 - E360
12345